Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Blood|August 5, 2008
Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ringYe-Xiong Li, Hui Fang, Qing-Feng Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphomaHua Wang, Ye-Xiong Li, Wei-Hu Wang, et al.
Hepatology (Baltimore, Md.)|June 7, 2021
Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCCBo Chen, Jian-Xiong Wu, Shu-Hui Cheng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvementNing-Ning Lu, Ye-Xiong Li, Run-Ye Wu, et al.
Leukemia & Lymphoma|February 18, 2011
Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type natural killer/T-cell lymphomaYe-Xiong Li, Hua Wang, Xiao-Li Feng, et al.
Radiation Oncology (London, England)|January 20, 2021
The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapyQiao-Xuan Wang, Rong Zhang, Wei-Wei Xiao, et al.
Annals of Hematology|October 27, 2012
Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal typeTing Zhao, Ye-Xiong Li, Shu-Lian Wang, et al.
Breast (Edinburgh, Scotland)|May 2, 2021
Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancerJing Yang, Shu-Nan Qi, Hui Fang, et al.
Medicine|May 27, 2016
Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular CarcinomaTao Zhang, Yu-Ting Zhao, Zhi Wang, et al.
Oncotarget|March 26, 2016
Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trialYan-Ru Feng, Yuan Zhu, Lu-Ying Liu, et al.
Pageof 9